TOKE 📈 Cambria Cannabis - Overview
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US1320618218 • Miscellaneous Sector
TOKE: Cannabis, Stocks, Swaps, Derivatives, ETFs, Cannabis Companies
The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing, under normal market conditions, primarily in Cannabis Companies, and total return swaps intended to provide exposure to Cannabis Companies.
Additional Sources for TOKE ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TOKE ETF Overview
| Market Cap in USD | 15m |
| Category | Miscellaneous Sector |
| TER | 0.42% |
| IPO / Inception | 2019-07-25 |
TOKE ETF Ratings
| Growth 5y | -71.7% |
| Fundamental | - |
| Dividend | 33.6% |
| Rel. Strength Industry | -143 |
| Analysts | - |
| Fair Price Momentum | 4.11 USD |
| Fair Price DCF | - |
TOKE Dividends
| Dividend Yield 12m | 7.02% |
| Yield on Cost 5y | 2.53% |
| Annual Growth 5y | -11.69% |
| Payout Consistency | 85.7% |
TOKE Growth Ratios
| Growth Correlation 3m | -85.9% |
| Growth Correlation 12m | -16.8% |
| Growth Correlation 5y | -82.2% |
| CAGR 5y | -18.46% |
| CAGR/Mean DD 5y | -0.34 |
| Sharpe Ratio 12m | -0.34 |
| Alpha | -36.99 |
| Beta | 1.04 |
| Volatility | 25.66% |
| Current Volume | 13.7k |
| Average Volume 20d | 21.7k |
What is the price of TOKE stocks?
As of January 15, 2025, the stock is trading at USD 4.84 with a total of 13,700 shares traded.
Over the past week, the price has changed by -4.82%, over one month by -1.57%, over three months by -14.64% and over the past year by -10.28%.
As of January 15, 2025, the stock is trading at USD 4.84 with a total of 13,700 shares traded.
Over the past week, the price has changed by -4.82%, over one month by -1.57%, over three months by -14.64% and over the past year by -10.28%.
Is Cambria Cannabis a good stock to buy?
No, based on ValueRay Analyses, Cambria Cannabis (BATS:TOKE) is currently (January 2025) a stock to sell. It has a ValueRay Growth Rating of -71.72 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TOKE as of January 2025 is 4.11. This means that TOKE is currently overvalued and has a potential downside of -15.08%.
No, based on ValueRay Analyses, Cambria Cannabis (BATS:TOKE) is currently (January 2025) a stock to sell. It has a ValueRay Growth Rating of -71.72 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TOKE as of January 2025 is 4.11. This means that TOKE is currently overvalued and has a potential downside of -15.08%.
Is TOKE a buy, sell or hold?
Cambria Cannabis has no consensus analysts rating.
Cambria Cannabis has no consensus analysts rating.
What are the forecast for TOKE stock price target?
According to ValueRays Forecast Model, TOKE Cambria Cannabis will be worth about 4.6 in January 2026. The stock is currently trading at 4.84. This means that the stock has a potential downside of -5.37%.
According to ValueRays Forecast Model, TOKE Cambria Cannabis will be worth about 4.6 in January 2026. The stock is currently trading at 4.84. This means that the stock has a potential downside of -5.37%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 4.6 | -5.4% |